QQQ   265.21 (-1.89%)
AAPL   107.06 (-2.97%)
MSFT   198.36 (-2.24%)
FB   252.02 (-1.10%)
GOOGL   1,448.94 (-2.56%)
AMZN   2,937.07 (-2.38%)
NVDA   483.11 (-3.10%)
TSLA   434.18 (+2.54%)
BABA   272.26 (-1.25%)
CGC   16.40 (+0.00%)
GE   6.96 (-1.28%)
MU   50.53 (-0.88%)
AMD   74.47 (-2.72%)
T   29.05 (-0.07%)
F   7.26 (-0.27%)
ACB   6.53 (-5.22%)
GILD   64.53 (-0.78%)
NFLX   464.00 (-1.32%)
DIS   129.12 (-0.84%)
BAC   25.41 (+0.24%)
BA   162.97 (-2.72%)
QQQ   265.21 (-1.89%)
AAPL   107.06 (-2.97%)
MSFT   198.36 (-2.24%)
FB   252.02 (-1.10%)
GOOGL   1,448.94 (-2.56%)
AMZN   2,937.07 (-2.38%)
NVDA   483.11 (-3.10%)
TSLA   434.18 (+2.54%)
BABA   272.26 (-1.25%)
CGC   16.40 (+0.00%)
GE   6.96 (-1.28%)
MU   50.53 (-0.88%)
AMD   74.47 (-2.72%)
T   29.05 (-0.07%)
F   7.26 (-0.27%)
ACB   6.53 (-5.22%)
GILD   64.53 (-0.78%)
NFLX   464.00 (-1.32%)
DIS   129.12 (-0.84%)
BAC   25.41 (+0.24%)
BA   162.97 (-2.72%)
QQQ   265.21 (-1.89%)
AAPL   107.06 (-2.97%)
MSFT   198.36 (-2.24%)
FB   252.02 (-1.10%)
GOOGL   1,448.94 (-2.56%)
AMZN   2,937.07 (-2.38%)
NVDA   483.11 (-3.10%)
TSLA   434.18 (+2.54%)
BABA   272.26 (-1.25%)
CGC   16.40 (+0.00%)
GE   6.96 (-1.28%)
MU   50.53 (-0.88%)
AMD   74.47 (-2.72%)
T   29.05 (-0.07%)
F   7.26 (-0.27%)
ACB   6.53 (-5.22%)
GILD   64.53 (-0.78%)
NFLX   464.00 (-1.32%)
DIS   129.12 (-0.84%)
BAC   25.41 (+0.24%)
BA   162.97 (-2.72%)
QQQ   265.21 (-1.89%)
AAPL   107.06 (-2.97%)
MSFT   198.36 (-2.24%)
FB   252.02 (-1.10%)
GOOGL   1,448.94 (-2.56%)
AMZN   2,937.07 (-2.38%)
NVDA   483.11 (-3.10%)
TSLA   434.18 (+2.54%)
BABA   272.26 (-1.25%)
CGC   16.40 (+0.00%)
GE   6.96 (-1.28%)
MU   50.53 (-0.88%)
AMD   74.47 (-2.72%)
T   29.05 (-0.07%)
F   7.26 (-0.27%)
ACB   6.53 (-5.22%)
GILD   64.53 (-0.78%)
NFLX   464.00 (-1.32%)
DIS   129.12 (-0.84%)
BAC   25.41 (+0.24%)
BA   162.97 (-2.72%)
Log in
NASDAQ:AGIO

Agios Pharmaceuticals SEC Filings & 10K Form

$38.20
-0.47 (-1.22 %)
(As of 09/18/2020 12:51 PM ET)
Add
Compare
Today's Range
$38.12
Now: $38.20
$38.78
50-Day Range
$36.97
MA: $40.97
$49.40
52-Week Range
$27.77
Now: $38.20
$56.74
Volume2,608 shs
Average Volume676,579 shs
Market Capitalization$2.64 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.86

SEC Filings

Agios Pharmaceuticals (NASDAQ:AGIO) SEC Filings

DateFilerForm TypeView
09/08/2020
3:09 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2020
3:24 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
9:25 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2020
6:17 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2020
6:04 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2020
4:14 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:14 PM
Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:14 PM
Agios Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:13 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:13 PM
Agios Pharmaceuticals (Issuer)
CLARK IAN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
6:19 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2020
3:18 PM
Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
3:02 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:55 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:53 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:52 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:51 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
3:50 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
3:05 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
3:21 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
6:40 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
6:23 AM
Agios Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
01/13/2020
3:32 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
5:43 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
3:24 PM
Agios Pharmaceuticals (Issuer)
Car Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2020
3:19 PM
Agios Pharmaceuticals (Issuer)
Car Bruce (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2020
1:01 PM
Agios Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/30/2019
3:08 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
3:02 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
3:07 PM
Agios Pharmaceuticals (Issuer)
Biller Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2019
3:02 PM
Agios Pharmaceuticals (Issuer)
Biller Jonathan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/22/2019
4:01 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:06 PM
Agios Pharmaceuticals (Issuer)
Celgene Alpine Investment Co., LLC (Reporting)
CELGENE CORP /DE/ (Reporting)
Celgene European Investment Co LLC (Reporting)
Celgene Switzerland LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
4:03 PM
Agios Pharmaceuticals (Filer)
Form 424B5
11/08/2019
3:57 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
4:09 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
8:14 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
6:39 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
6:20 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2019
3:20 PM
Agios Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
09/30/2019
10:13 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
4:05 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
7:56 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:29 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
11:41 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
06/13/2019
3:07 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:08 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
3:02 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
3:08 PM
Agios Pharmaceuticals (Issuer)
Scadden David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:08 PM
Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:07 PM
Agios Pharmaceuticals (Issuer)
Ho Maykin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:05 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:05 PM
Agios Pharmaceuticals (Issuer)
Foster-Cheek Kaye I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:04 PM
Agios Pharmaceuticals (Issuer)
CLARK IAN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
3:03 PM
Agios Pharmaceuticals (Issuer)
Clancy Paul J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:13 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
2:24 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
7:57 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:24 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
10:46 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
04/26/2019
10:06 AM
Agios Pharmaceuticals (Filer)
Form CT ORDER
04/24/2019
4:38 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:07 PM
Agios Pharmaceuticals (Filer)
Form DEFA14A
04/18/2019
3:04 PM
Agios Pharmaceuticals (Filer)
Form DEF 14A
04/09/2019
3:59 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
3:25 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
3:06 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:04 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:27 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:25 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:24 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:21 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2019
3:02 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
3:03 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:05 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:04 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:03 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
3:01 PM
Agios Pharmaceuticals (Issuer)
Alenson Carman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
8:07 AM
Agios Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2019
7:48 AM
Agios Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
6:16 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
10:18 AM
Agios Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2019
3:28 PM
Agios Pharmaceuticals (Issuer)
FOUSE JACQUALYN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
9:09 AM
Agios Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/31/2019
2:03 PM
Agios Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
01/28/2019
3:01 PM
Agios Pharmaceuticals (Subject)
BB BIOTECH AG (Filed by)
Form SC 13G/A
01/23/2019
3:22 PM
Agios Pharmaceuticals (Issuer)
Hirsch Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:19 PM
Agios Pharmaceuticals (Issuer)
Hoerter Steven L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:12 PM
Agios Pharmaceuticals (Issuer)
Bowden Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
6:48 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2018
3:39 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2018
3:30 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
3:03 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2018
3:01 PM
Agios Pharmaceuticals (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2018
3:01 PM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
3:09 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2018
3:12 PM
Agios Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4/A
11/01/2018
8:33 AM
Agios Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
6:45 AM
Agios Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2018
3:09 PM
Agios Pharmaceuticals (Issuer)
Biller Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.